Loading organizations...
D&I Investment operates as an investment firm dedicated to fostering appropriate capital returns and sustainable growth within its portfolio companies. The firm applies a distinct investment strategy focused on long-term commitment, prioritizing companies' inherent potential over short-term financial gains. It actively supports management teams in optimizing asset utilization, integrating diverse talent, and implementing robust governance frameworks to enhance enterprise value.
The firm was founded in 2021 by a team including Kankuro Ueshima, Tetsuji Fuwa, and Haruka Kurokawa, who brought diverse backgrounds in entrepreneurship, investment banking, and legal expertise. Their foundational insight stems from the belief that a Dividend on Equity (DOE) of 5% serves as a critical minimum benchmark for shareholder returns, reflecting a commitment to shareholder value and efficient capital allocation. This philosophy guides their engagement with invested entities.
D&I Investment serves a broad spectrum of companies, including those at various growth stages, regardless of their size or public status, that are poised for unlocking latent value. Its overarching vision is to contribute to the vitality of the Japanese economy by facilitating the constructive circulation of capital towards productive economic activities. The firm endeavors to foster robust growth, effective governance, and diverse human capital across its investments.
D&I Investment has 1 tracked investment across 1 company. The latest tracked deal is $15.4M Other Equity in Elephantech in November 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 17, 2022 | Elephantech | $15.4M Other Equity | — | ANRI, Beyond Next Ventures, East Ventures, Eiwa Corporation, Epson, Kenbishi Sake Brewing, Mitsubishi GAS Chemical, Nanobank, Nose, Shin Etsu Chemical, Shizuoka Capital, Sumimoto |